Dbl Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DBL PHARMS, and what generic and branded alternatives to DBL PHARMS drugs are available?
DBL PHARMS has one approved drug.
Drugs and US Patents for Dbl Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dbl Pharms | METHOCARBAMOL | methocarbamol | TABLET;ORAL | 203550-002 | Feb 8, 2017 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Dbl Pharms | METHOCARBAMOL | methocarbamol | TABLET;ORAL | 203550-001 | Feb 8, 2017 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.